Search details
1.
Combined BRAF, MEK, and heat-shock protein 90 inhibition in advanced BRAF V600-mutant melanoma.
Cancer
; 130(2): 232-243, 2024 01.
Article
in English
| MEDLINE | ID: mdl-37776537
2.
Radar-Guided Localization and Resection for Metastatic Nodal and Soft Tissue Melanoma: A Single-Institution Retrospective Study.
Cancer Control
; 31: 10732748241237907, 2024.
Article
in English
| MEDLINE | ID: mdl-38429650
3.
Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.
CA Cancer J Clin
; 67(6): 472-492, 2017 Nov.
Article
in English
| MEDLINE | ID: mdl-29028110
4.
Melanoma in Pediatric and Young Adult Patients.
Curr Oncol Rep
; 2024 May 23.
Article
in English
| MEDLINE | ID: mdl-38780675
5.
International Center-Level Variation in Utilization of Completion Lymph Node Dissection and Adjuvant Systemic Therapy for Sentinel Lymph Node-Positive Melanoma at Major Referral Centers.
Ann Surg
; 277(5): e1106-e1115, 2023 05 01.
Article
in English
| MEDLINE | ID: mdl-35129464
6.
Pembrolizumab versus placebo as adjuvant therapy in completely resected stage IIB or IIC melanoma (KEYNOTE-716): a randomised, double-blind, phase 3 trial.
Lancet
; 399(10336): 1718-1729, 2022 04 30.
Article
in English
| MEDLINE | ID: mdl-35367007
7.
Combined nivolumab and ipilimumab with or without stereotactic body radiation therapy for advanced Merkel cell carcinoma: a randomised, open label, phase 2 trial.
Lancet
; 400(10357): 1008-1019, 2022 09 24.
Article
in English
| MEDLINE | ID: mdl-36108657
8.
Melanoma and CLL co-occurrence and survival: role of KC history.
BMC Cancer
; 23(1): 1084, 2023 Nov 09.
Article
in English
| MEDLINE | ID: mdl-37946198
9.
Atypical Fibroxanthoma: Outcomes from a Large Single Institution Series.
Cancer Control
; 30: 10732748231155699, 2023.
Article
in English
| MEDLINE | ID: mdl-36764930
10.
Sentinel lymph node biopsy in patients with T1a cutaneous malignant melanoma: A multicenter cohort study.
J Am Acad Dermatol
; 88(1): 52-59, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36184008
11.
Patient-reported tolerability of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon alfa-2b for resected high-risk stage III-IV melanoma in phase III trial E1609.
Qual Life Res
; 32(1): 183-196, 2023 Jan.
Article
in English
| MEDLINE | ID: mdl-36029412
12.
Acral melanoma: clinical advances and hope for the future.
Clin Adv Hematol Oncol
; 21(8): 400-409, 2023 Aug.
Article
in English
| MEDLINE | ID: mdl-37530614
13.
Natural History of Incident and Persistent Cutaneous Human Papillomavirus and Human Polyomavirus Infections.
J Infect Dis
; 226(7): 1162-1174, 2022 09 28.
Article
in English
| MEDLINE | ID: mdl-35022780
14.
Current and future approaches in the surgical management of T3b/T4 primary and locoregionally advanced melanoma.
Cancer
; 128(21): 3764-3771, 2022 11 01.
Article
in English
| MEDLINE | ID: mdl-36066835
15.
Is the presence of tumor-infiltrating lymphocytes predictive of outcomes in patients with melanoma?
Cancer
; 128(7): 1418-1428, 2022 04 01.
Article
in English
| MEDLINE | ID: mdl-35103302
16.
Enhanced immune activation within the tumor microenvironment and circulation of female high-risk melanoma patients and improved survival with adjuvant CTLA4 blockade compared to males.
J Transl Med
; 20(1): 253, 2022 06 03.
Article
in English
| MEDLINE | ID: mdl-35659704
17.
Evaluation of the Indications for Sentinel Node Biopsy in Early-Stage Melanoma with the Advent of Adjuvant Systemic Therapy: An International, Multicenter Study.
Ann Surg Oncol
; 29(9): 5937-5945, 2022 Sep.
Article
in English
| MEDLINE | ID: mdl-35562521
18.
An Internally Validated Prognostic Risk-Score Model for Disease-Specific Survival in Clinical Stage I and II Merkel Cell Carcinoma.
Ann Surg Oncol
; 29(11): 7033-7044, 2022 Oct.
Article
in English
| MEDLINE | ID: mdl-35867209
19.
Neoadjuvant Systemic Therapy (NAST) in Patients with Melanoma: Surgical Considerations by the International Neoadjuvant Melanoma Consortium (INMC).
Ann Surg Oncol
; 29(6): 3694-3708, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-35089452
20.
Regression in melanoma is significantly associated with a lower regional recurrence rate and better recurrence-free survival.
J Surg Oncol
; 125(2): 229-238, 2022 Feb.
Article
in English
| MEDLINE | ID: mdl-34535899